Objective: To review experience with diagnosis, clinical associations, and outcomes of vasa previa in a single institution.
Methods: This was a retrospective review of all identified vasa previa cases from January 1 1990, to June 30, 2010.
Results: Sixty cases of vasa previa were identified (53 singletons, seven twins); 56 cases were diagnosed before delivery. An abnormal cord insertion or abnormal placental location was present in 55 cases. Missed diagnoses were attributed to technical and observer factors. Preterm bleeding was encountered in 25 (42%) case group participants. Seven case group participants required an emergent delivery, with significant neonatal morbidity and mortality. Twin pregnancies had a significantly earlier median age at delivery of 32 weeks of gestation compared with 35 weeks of gestations in singletons (P=.01). The seven twin pregnancies had a 28.6% emergent preterm delivery rate, whereas singletons had a 4.1% rate (P=.07). In 14 case group participants, the membranous fetal vessel was located in the lower uterus and not directly over the cervix. The vessel location was not related to the risk of emergent delivery.
Conclusion: Transvaginal ultrasound scans of at-risk patients can identify most cases of vasa previa. Preterm bleeding does not usually require immediate delivery. The rate of emergent preterm delivery was low in singleton pregnancies. Twins were delivered, on average, 3 weeks earlier than singletons.
Level Of Evidence: III.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/AOG.0b013e31829cac58 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Evidence-based Diagnosis and Treatment of Vasa Previa.
Clin Obstet Gynecol
March 2025
Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, NYU Langone Health, New York, NY.
Vasa previa is an abnormality of the umbilical cord and fetal membranes that affects ∼1 in 1300 pregnancies. The diagnosis is made by visualization of velamentous fetal vessels coursing within the membranes over the cervix unprotected by Wharton jelly or placenta. When it is not diagnosed prenatally, it is associated with a high risk of fetal death.
View Article and Find Full Text PDFVasa previa guidelines and their supporting evidence.
J Perinat Med
January 2025
Department of Obstetrics & Gynaecology, 2541 Monash University, Melbourne, VIC, Australia.
Article Synopsis
- Vasa previa (VP) is a serious complication where fetal blood vessels are vulnerable near the cervix, requiring cesarean delivery before labor to avoid severe risks.
- Different obstetric organizations have varying guidelines on managing VP, especially regarding hospitalization, steroid use, and delivery timing for asymptomatic patients.
- Current guidelines lack robustness, relying on low-quality evidence and not incorporating new research insights, highlighting the need for more substantial evidence for improved management strategies.
Prenatal diagnosis of total vasa previa using 2D and HD live flow combined with spatiotemporal correlation: a case series description.
Quant Imaging Med Surg
December 2024
Ultrasound Medicine Center, Gansu Provincial Maternity and Child-care Hospital, Lanzhou, China.
Prenatal diagnosis of vasa praevia in routine clinical practice: Prevention of stillbirths and impact on perinatal outcomes.
Eur J Obstet Gynecol Reprod Biol
February 2025
Medway Fetal and Maternal Medicine Centre, Gillingham, UK; Institute of Medical Sciences, Canterbury Christ Church University, Kent, UK. Electronic address:
Article Synopsis
- Vasa praevia (VP) is a serious condition where fetal blood vessels are near the cervix, and detecting it before birth can significantly improve baby survival rates.
- The study aimed to demonstrate a two-stage ultrasound screening process for identifying VP during routine prenatal care, which could help prevent stillbirths and perinatal deaths.
- Analyzing data from over 53,000 pregnancies, the study found that VP occurred in about 1 in 1,192 pregnancies, with specific factors like low-lying placenta and placenta previa being strong indicators of the condition.
Management strategy and experience of vasa previa in perinatal centers: A nationwide survey in Japan.
J Obstet Gynaecol Res
January 2025
Department of Obstetrics and Gynecology, Jichi Medical University, Shimotsuke, Tochigi, Japan.
Aim: To clarify the current situation and outcomes of vasa previa (VP) in Japan.
Methods: A questionnaire survey on VP was conducted at all 408 perinatal centers in Japan. The content of the survey included (1) the management strategy for pregnant women who were diagnosed with VP and (2) the number and outcomes of VP cases managed between January 2020 and December 2022.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!